4-amino-2-(4-butanoylhexahydro-1H-1,4-diazepin-1-yl)-6,7-dimethoxyquinazoline HCl,
Andante,
bunazocine,
bunazosin,
bunazosin hydrochloride,
E 643,
E-643,
E643,
bunazosin hydrochloride,
52712-76-2,
Detantol,
DDQ (pharmaceutical),
Bunazocine hydrochloride,
UNII-18V54TZ7U6,
1-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl)butan-1-one hydrochloride,
E-643,
E643,
18V54TZ7U6,
1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one hydrochloride(1:1),
4-Amino-2-(4-butanoylhexahydro-1H-1,4-diazepin-1-yl)-6,7-dimethoxyquinazoline hydrochloride,
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1-oxobutyl)hexahydro-1H-1,4-diazepine monohydrochloride,
1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one hydrochloride,
1H-1,4-Diazepine, hexahydro-1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1-oxobutyl)-, monohydrochloride,
NCGC00183272-01,
Andante,
Bunazosin hydrochloride [JAN],
Detantol (TN),
AC1L3GWT,
DSSTox_CID_28514,
DSSTox_RID_82786,
DSSTox_GSID_48588,
C19H27N5O3.HCl,
SCHEMBL349737,
AC1Q3E26,
Bunazosin hydrochloride (JP17),
CHEMBL3182014,
DTXSID7048588,
CHEBI:31320,
CTK8D7931,
Tox21_112917,
AKOS016014364,
API0002269,
ACM52712762,
AN-40902,
LS-60196,
SC-49932,
AX8118964,
CAS-52712-76-2,
FT-0659022,
D01887,
C-23867,
1-[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one hydrochloride,
1H-1,4-Diazepine, hexahydro-1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1-oxobutyl)-,monohydrochloride,
1H-1,4-Diazepine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-4-(1-oxobutyl)-,monohydrochloride,
Bunazosin HCl,
Bunazosinhydrochloride,
Shpmp-angiotensin II,
C19H27N5O3.ClH,
KST-1B5026,
C19-H27-N5-O3.Cl-H,
AR-1B9246,
CID115305,
52712-76-2 (HCl),
E-1015,
1-Sar-7-hydroxy-pro-8-N-methyl-phe-angiotensin II,
53819-93-5,
Angiotensin II, sar(1)-hydroxy-pro(7)-N-Me-phe(8)-,
DDQ,
1-Sarcosyl-7-hydroxyprolyl-8-N-methylphenylalanine-angiotensin II,
Angiotensin II, sarcosyl(1)-hydroxyprolyl(7)-N-methylphenylalanine(8)-,